Why are Minimally Invasive Block (MIB) injections, also known as Medial Branch Blocks (MBB), limited to 2 levels and no more than 8 injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medial Branch Block Limitations: 2 Levels and 8 Injections Maximum

The American College of Neurosurgery recommends limiting medial branch blocks to one invasive modality at a time, and performing only one procedure at a time for back pain treatment, which translates to restricting the number of levels and total injections to minimize false positives, reduce complications, and maintain diagnostic specificity. 1

Safety and Technical Considerations

Volume-Related Spread and Specificity

  • Each medial branch block injection should use minimal volumes (0.25 mL rather than 0.50 mL) to prevent unintended spread to adjacent structures, which decreases diagnostic specificity and increases false-positive rates. 2

  • Larger injection volumes (0.50 mL) reliably spread to superficial muscles and distant nerves not targeted by subsequent radiofrequency ablation, contaminating the diagnostic value of the block. 2

  • Limiting to 2 levels (typically 4 nerves, requiring 4 injections bilaterally, totaling 8 injections) maintains adequate diagnostic accuracy while preventing excessive local anesthetic spread that would make it impossible to determine which specific level is the true pain generator. 2

Intravascular Injection Risk

  • The incidence of intravascular uptake during lumbar medial branch blocks is 6.1% per nerve block, and this risk increases proportionally with the number of injections performed. 3

  • Preinjection aspiration alone has only 34.1% sensitivity for detecting intravascular placement, meaning multiple injections compound the risk of systemic local anesthetic toxicity. 3

  • Performing more than 8 injections significantly increases the cumulative risk of intravascular injection and potential systemic complications, including local anesthetic toxicity. 3

Diagnostic Validity and False-Positive Prevention

Sequential Assessment Requirements

  • A sequential approach rather than simultaneous multi-level procedures allows for better assessment of which specific level provides the most benefit and more accurate identification of the primary pain generator. 1

  • The double-injection technique with an 80% improvement threshold is recommended to establish diagnosis, but this requires limiting the number of levels tested to maintain diagnostic clarity. 1

  • Performing blocks at more than 2 levels simultaneously makes it impossible to determine which specific facet joints are responsible for pain relief, leading to unnecessary radiofrequency ablation at non-painful levels. 4, 1

False-Positive Rate Management

  • False-positive rates for medial branch blocks range from 27% to 63%, and this rate increases when multiple levels are blocked simultaneously due to overlapping anesthetic spread. 2

  • Limiting injections to 8 (covering 2 bilateral levels) helps maintain the specificity needed for subsequent radiofrequency ablation planning. 2

  • Patients who receive blocks at more than 2 levels cannot reliably distinguish which level provided relief, compromising the validity of subsequent therapeutic interventions. 5

Clinical Practice Standards

Guideline-Based Restrictions

  • Clinical practice guidelines specifically state that only one invasive modality or procedure should be considered medically necessary at a time for back pain treatment. 1

  • The restriction to 2 levels (8 injections maximum) aligns with evidence-based protocols that prioritize diagnostic accuracy over comprehensive but non-specific pain relief. 4, 1

  • Performing medial branch blocks at more than 2 levels is not supported by medical necessity criteria established by major pain medicine societies. 1

Therapeutic Efficacy Considerations

  • Studies demonstrating effectiveness of radiofrequency ablation following medial branch blocks used protocols limiting diagnostic blocks to specific levels rather than widespread multi-level injections. 5

  • The 54% success rate for radiofrequency ablation following medial branch blocks depends on accurate level identification, which is compromised when too many levels are blocked simultaneously. 5

  • Patients selected by ≥80% symptom relief with dual concordant blocks at limited levels show consistent outcomes, supporting the restriction to 2 levels maximum. 5

Common Pitfalls to Avoid

  • Avoid the temptation to block multiple levels simultaneously "just to be thorough" – this destroys diagnostic specificity and leads to unnecessary radiofrequency ablation procedures. 1, 2

  • Do not assume that more injections provide better diagnostic information; the opposite is true due to overlapping anesthetic effects. 2

  • Recognize that exceeding 8 injections (2 bilateral levels) significantly increases complication risk without improving diagnostic accuracy. 3

  • Ensure real-time fluoroscopy during each injection rather than relying on aspiration alone, as this becomes increasingly critical with higher injection numbers. 3

Related Questions

What should I ask a patient who received a C5,6,7 medial branch block (MBB)?
Is it acceptable to perform three levels of left cervical Medial Branch Blocks (MBBs) in a single patient?
Is another cervical facet medial branch (MBB) nerve block and left occipital nerve block medically appropriate for a patient with temporary relief and significant pain after the previous procedure?
Is a medial branch block (MBB) helpful for managing pain due to compression fractures?
How long do diagnostic medial branch blocks provide relief prior to radiofrequency (RF) ablation?
What is the recommended protocol for switching from Vyvanse (lisdexamfetamine) to Strattera (atomoxetine)?
What is the appropriate workup and treatment for a patient with suspected glomerulonephritis (inflammation of the glomeruli in the kidneys)?
Is low-dose Seroquel (quetiapine) effective for short-term management of sleep disturbances and anxiety agitation?
What lab tests should be ordered to diagnose and monitor hepatitis B?
What is the role of Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors in reducing the risk of heart failure, Chronic Kidney Disease (CKD), and mortality beyond glycemic control in patients with type 2 diabetes?
What is the most appropriate treatment plan for a patient with HIV (Human Immunodeficiency Virus) and HCV (Hepatitis C Virus) genotype 1a, taking darunavir (Prezista), ritonavir (Norvir), and emtricitabine/tenofovir alafenamide (Descovy), with normal CD4 (Cluster of Differentiation 4) count and undetectable HIV RNA (Ribonucleic Acid)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.